Latest filing published 05 Oct 2026 for 4D Molecular Therapeutics, Inc., €671k.
Insider track record
David Kirn: trading record in brief
David Kirn discloses dealings in 4D Molecular Therapeutics, Inc. to SEC (Form 4). Between 22 June 2026 and 5 October 2026, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 5 October 2026 with a transaction (€671k) in 4D Molecular Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Kirn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 58,333 shares@ US$12.92Class A CommonSEC144:0001958244-26-000638
- 58,333 shares@ US$13.760.097% mcap18.5% of flowClass A CommonSEC144:0001958244-26-000601
- 69,076 shares@ US$16.760.14% mcap26.8% of flowClass A CommonSEC144:0001958244-26-000539
- 26,842 shares@ US$10.260.033% mcap6.4% of flowClass A CommonSEC144:0001958244-26-000477
- 12,415 shares@ US$10.090.015% mcap2.9% of flowClass A CommonSEC144:0001958244-26-000473
- 15,725 shares@ US$12.310.024% mcap4.5% of flowClass A CommonSEC144:0001958244-26-000446
- 42,608 shares@ US$12.890.067% mcap12.9% of flowClass A CommonSEC144:0001958244-26-000444
- 114,746 shares@ US$10.420.13% mcap28.0% of flowClass A CommonSEC144:0001958244-26-000396
8 of 8 declarations
